An interventional study of traning seminar in Respiratory Tract Diseases, Respiratory Tract Infections and Pneumonia, Ventilator-Associated, sponsored by Jagiellonian University. Completed at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-07-31.
Sponsored by Jagiellonian University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
There is no accepted standard for the frequency of monitoring endotracheal tube cuff pressures (ETCP). the investigators plan on comparing two strategies for monitoring ETCP in mechanically ventilated patients.
Nowadays ETCP is evaluated once every 24 hours. Next, the investigator want to conduct training for medical and nursing staff. After the training, ETCP will be measured every 8 hours.
The aim of the study is to prove that more frequent pressure control (3 times a day) reduces the occurrence of abnormal ETCP.
410 studies on the registry are indexed under Respiratory Tract Diseases; 59 are open to participants now.
This study's enrollment of 188 is above the median of 117 across 316 interventional studies indexed under Respiratory Tract Diseases.
Browse Respiratory Tract Diseases studies →Jagiellonian University is the lead sponsor of 161 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Cuff pressure checks once a day.
Other: traning seminar
Cuff pressure checks three times a day
Other: traning seminar
There will be provided 30 min training seminar on the function of endotracheal cuff and cuff pressure.
monitoring of cuff pressures
The effectiveness of pressure monitoring in various time intervals
Time frame: 1 year
preventing complications of incorrect pressure in tracheal cuff
preventing of an VAP or airway damage
Time frame: 5 years
Plan to share: Undecided — We are undecided on this point.
No publications or documents are linked to this record.
Ran from Oct 2017 to primary completion in Jun 2018, 8 months.
Of 46 non-industry interventional studies with no phase under Respiratory Tract Diseases, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 74. This study's 8 months is below that.
Counting every sponsor, half of 52 studies reached it within 30 months; a quarter within 11 and three quarters within 74.
Respiratory Tract Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.